COMMUNIQUÉS West-GlobeNewswire

In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
06/08/2019
Updated Cancer Risk Estimates Will Allow For More Personalized Risk Assessment and Informed Decision Making For Patients with Rare Form of Hereditary Stomach Cancer GAITHERSBURG, Md., Aug. 06, 2019 (GLOBE NEWSWIRE) -- [...]
Entasis Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
WALTHAM, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal of Neurodevelopmental Disorders
06/08/2019
DEVON, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Passage Bio to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
PHILADELPHIA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that [...]
Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor
06/08/2019
Dr. Briscoe to advise company on ongoing development of therapeutics based on the Neuropilin-2 (NRP2) co-receptor and related signaling pathways SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]
Replimune to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
WOBURN, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced that Philip [...]
CytomX Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
06/08/2019
Conference Call Scheduled for Tuesday, August 13, 2019 at 9:00 AM ET PORTLAND, Maine, Aug. 06, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company [...]
Spring Bank Announces Collaborative Research Agreement with University of Texas Southwestern Medical School for Evaluation of STING Antagonist Compounds
06/08/2019
HOPKINTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
06/08/2019
FDA Breakthrough Therapy Designation Received for Pegzilarginase in Treatment of Arginase 1 Deficiency Dosed First Patient in Global Pivotal Phase 3 PEACE Trial New Data from Arginase 1 Deficiency Phase 2 Extension [...]
MediWound to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 13
06/08/2019
YAVNE, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Immutep Completes A$6M Entitlement Offer
06/08/2019
SYDNEY, Australia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”) is pleased to announce the completion of its fully underwritten pro rata non-renounceable [...]
Seoul National University Hospital and Syapse Sign Multi-Year Renewal Agreement to Expand Access to Precision Medicine in South Korea
06/08/2019
Syapse and SNUH will work together to build Asia’s first learning health network of real-world data derived from the region’s leading precision oncology hospitals Co-hosted symposium of East Asian hospitals will share [...]
Avricore Health Welcomes Kiki Smith as Chief Financial Officer
06/08/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
Arbutus to Participate at Wedbush PacGrow Healthcare Conference
06/08/2019
WARMINSTER, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia will [...]
Kiniksa Pharmaceuticals to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
HAMILTON, Bermuda, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa, will present at the [...]

Pages